# Virtual-reality Induced Immune Modulation in Allergic Patients

> **NCT07721233** · NA · NOT_YET_RECRUITING · sponsor: **University of Geneva, Switzerland** · enrollment: 81 (estimated)

## Conditions studied

- Hymenoptera Venom Allergy

## Interventions

- **BEHAVIORAL:** Allergen-related immersive virtual reality exposure
- **BEHAVIORAL:** Control immersive virtual reality exposure

## Key facts

- **NCT ID:** NCT07721233
- **Lead sponsor:** University of Geneva, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-01
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721233, "Virtual-reality Induced Immune Modulation in Allergic Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*